General Cybernetics
Boston biotech working on gene editing in embryos to prevent genetic disease. Raised $15.3M.
Updated · 12 sources · Markdown
General Cybernetics is a Boston biotech company developing gene editors for use in embryos, with the stated goal of preventing genetic disease. Its team has described a CRISPR editor with a built-in off-switch, and a hiring post describes "controllable gene editors with inducible safety switches". A Form D filed with the SEC on 2026-09-09 shows $15,306,982 sold to 36 investors, including SAFEs that converted into equity. Autumn found this company from that SEC Form D. Its website says the company is in stealth, and no news article about it or the round was found as of 2026-11-16.
The first public record is from July 3, 2023. No press found as of November 16, 2026. The record that gave it away is an SEC Form D dated September 9, 2026.
- Raised
- $15.3MSEC Form D, total sold
- Domain registration → no press yet
- 1,232 daysJul 3, 2023 to Nov 16, 2026, still no pressDomain registration: RDAP: generalcybernetics.org ↗
- Gave it away
- SEC Form DSep 9, 2026
- Based in
- Boston, MA
- Founders
- Aydin GokceCofounder and CEO
The record that gave it away

The paper trail
Dated records in order, each with its source. Certificate validity starts can precede CT logging, so they do not always establish an exact first-public date.
What the site says todayComing soon. This company is currently in stealth.
- Domain registration
generalcybernetics.org registered
The current registration record for generalcybernetics.org was created on 2023-07-03. The record does not show who registered it.
Sources1rdap.org - Incorporation filing
Incorporated in Delaware
The Form D gives 2024 as the year of incorporation and Delaware as the jurisdiction. The exact date is not in the filing.
Sources1sec.gov - Founder departure
Cofounder leaves Saronic
Aydin Gokce's public profile lists a software engineering role at Saronic Technologies ending in 2024. A Foresight Institute profile describes him as a cofounder at General Cybernetics who previously worked at Saronic.
- Website
First archived page under the company name
The Wayback Machine's first capture of the current site is a page titled "General Cybernetics" with no other text.
Sources1web.archive.org - 312 days laterPublic record
Presentation to a New Hampshire legislative caucus
Aydin Gokce and Genesis Lung presented "Safer Gene Editing Technologies in Reproductive Medicine" to the New Hampshire Emerging Technologies Caucus. The caucus notes describe a CRISPR editor with a built-in off-switch meant to avoid mosaicism in embryos.
Sources1emergingtechnh.org - 72 days laterWebsite
Site says "Launching Q2 2026"
An archived copy of the homepage shows a logo, the line "Launching Q2 2026" and a contact button. The page description reads "Next-Gen Reproductive Therapies."
Sources1web.archive.org - Public record
CEO speaks on embryo editing at FII PRIORITY Miami
The FII Institute's recap of a biotech session quotes Aydin Gokce, identified as CEO of General Cybernetics, saying "The things you can cure now are genetic diseases" and describing embryo editing to correct pathogenic mutations.
Sources1fii-institute.org - 34 days laterJob posting
Hiring post for two research roles
Genesis Lung posted that General Cybernetics is hiring a research associate and a research scientist, calling it "an early startup with several million in current funding". Applicants were told to write to an address at generalcybernetics.org. The post went up 133 days before the Form D.
Sources1linkedin.com - 119 days laterFunding
Date of first sale in the round
The Form D gives 2026-08-26 as the date of first sale.
Sources1sec.gov - 14 days laterSEC Form D
SEC Form D filed: $15.3M sold
The filing reports $15,306,982 offered and sold to 36 investors, in equity and "SAFEs converted into equity in this transaction". It names Aydin Gokce as executive officer and director, signing as Chief Executive Officer, and Viraj Chhajed as a director.
Sources1sec.gov - 68 days laterWebsite
Site says the company is in stealth
The homepage shows "Coming soon. This company is currently in stealth." above a password field. The Q2 2026 launch line is gone.
Sources1generalcybernetics.org - Press
No press found as of November 16, 2026
The records themselves
Captures of the other public documents behind the trail. Each one links to the full record at its source.

The website, then and now


In March 2026 the homepage said "Launching Q2 2026". In November 2026 it says the company is in stealth and asks for a password.
The founder
What we don't know
- Who the 36 investors are. The Form D names none.
- The exact incorporation date. The Form D gives only the year, 2024.
- Who registered generalcybernetics.org in 2023, before the stated year of incorporation.
- Whether the Q2 2026 launch on the March 2026 homepage happened in any form.
- How far the research has progressed. No paper, patent or regulatory filing was found as of 2026-11-16.
Sources
- rdap.org/domain/generalcybernetics.org
- sec.gov/Archives/edgar/data/2154072/000215407226000001/primary_doc.xml
- linkedin.com/in/aydin-gokce
- foresight.org/people/aydin-gokce/
- web.archive.org/web/20250227044844/https://generalcybernetics.org/
- emergingtechnh.org/events/694017122a90f7a559833c88
- web.archive.org/web/20260318093206/https://generalcybernetics.org/
- fii-institute.org/press/this-article-draws-on-two-afternoon-sessions-at-fii-priority-miami-2026-fii-hotseat-biotech-as-freedom-and-how-to-define-champions-of-the-intelligence-age/
- linkedin.com/posts/genesis-lung-123ab993_general-cybernetics-is-hiring-we-are-an-activity-7455360974276177920-ZUOw
- generalcybernetics.org/
- sec.gov/Archives/edgar/data/2154072/000215407226000001/xslFormDX01/primary_doc.xml
- sec.gov/Archives/edgar/data/2154072/000215407226000001/0002154072-26-000001-index.htm
The Autumn prompt
Profile these five companies that surfaced through SEC Form D filings, one row per company: General Cybernetics (embryo gene editing), Kunin Technologies (critical minerals from mining waste), Path Power (autonomous underground drilling robot for power lines), Autonymy (founded by ex-Anduril people) and Fluidstack (AI cloud). For each, give the legal name, what it does, sector, HQ, website and what the site says today, every founder and named officer, and a dated paper trail: incorporation, domain registration, each Form D (filing date, date of first sale, amount sold), patents, job posts, founder departures from prior employers, subdomains and the first press coverage with outlet and date. Include a source URL for each field.
- Records
- 11
- Signals
- 6
- Sources
- 12